4//SEC Filing
PASSERI DANIEL R 4
Accession 0001209191-22-021449
CIK 0001645460other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:08 PM ET
Size
5.4 KB
Accession
0001209191-22-021449
Insider Transaction Report
Form 4
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2022-03-25+100,000→ 100,000 totalExercise: $5.01Exp: 2032-03-24→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001190121
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:08 PM ET
- Size
- 5.4 KB